文献速递肿瘤 PET/CT

长轴视野PET/CT在同日短轴视野PET/CT患者中的临床附加价值:初步经验与探索性研究

Clinical added value of LAFOV PET/CT in patients undergoing same-day [18 F]FDG SAFOV PET/CT scans: an initial experience report and explorative study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-10-24

本研究纳入124例因肿瘤及非肿瘤指征行[18F]FDG PET/CT的患者,同日分别用短轴视野(SAFOV)和长轴视野(LAFOV,uEXPLORER)系统采集,由三名核医学医师独立判读。LAFOV较SAFOV多检出52个病灶(27例患者),患者水平一致率85%,15%患者因LAFOV结果改变临床管理。

要点

  • LAFOV PET/CT较SAFOV多检出52个病灶,患者水平一致率85%。
  • LAFOV额外发现的病灶中42%被确认为真阳性,15%患者管理改变。
  • LAFOV判读者间一致性几乎完美(Fleiss k=0.853),高于SAFOV(0.787)。

核心结论

  • LAFOV PET/CT显著改善病灶检出并影响临床决策,仍需前瞻性研究验证其临床效用。

研究设计与样本

  • 2024年6月至12月连续纳入因肿瘤及非肿瘤指征行[18F]FDG PET/CT的患者,同日行SAFOV与LAFOV(uEXPLORER)配对采集。
  • 共124例患者(64%女性,中位年龄65.5岁),由三名核医学医师独立判读,行患者水平与病灶水平分析。
  • 统计分析包括kappa统计、Wilcoxon符号秩检验和Spearman相关系数。

主要发现

  • SAFOV与LAFOV判读者间一致性分别为Fleiss k=0.787(substantial)和0.853(almost perfect)。
  • 患者水平两扫描一致率85%(Cohen k=0.73);病灶水平一致率76%(p<0.05)。
  • SAFOV检出274个病灶,LAFOV检出323个;LAFOV在27例患者中额外检出52个发现(p<0.05)。
  • LAFOV额外发现的病灶中42%确认为真阳性。
  • LAFOV结果使15%患者临床管理改变,其中68%为重大治疗改变。

临床怎么用

  • 在常规诊断流程中,LAFOV PET/CT可提高病灶检出率并可能改变部分患者的治疗决策。
  • 判读LAFOV图像时需注意额外发现的病灶中约四成为真阳性,应结合临床确认。

局限性

  • 本研究为初步经验报告与探索性研究,需进一步前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The uEXPLORER is the first total-body, long-axial field-of-view (LAFOV) PET/CT system available for diagnostic use. The present study aims to assess its clinical impact, with a particular focus on management changes resulting from its use in routine diagnostic workflows. METHODS: From June to December 2024, consecutive patients undergoing [18 F]FDG PET/CT for both oncologic and non-oncologic indications were considered for paired acquisitions using short-axial field-of-view (SAFOV) and LAFOV (uEXPLORER) systems. Scans were independently reviewed by three nuclear medicine physicians. Per-patient and per-lesion analyses were performed. Subsequent clinical management decisions were evaluated to determine the impact of LAFOV imaging. Statistical analyses included kappa statistics, Wilcoxon Signed-Rank Test, and Spearman's correlation coefficient. RESULTS: A total of 124 patients (64% female; median age 65.5 years) were enrolled. Inter-reader agreement was substantial for SAFOV scans (Fleiss' k = 0.787) and almost perfect for LAFOV scans (Fleiss' k = 0.853). In per-patient analysis, the two scans were concordant in 85% of cases (Cohen's k = 0.73). Total lesions identified were 274 on SAFOV PET/CT and 323 on LAFOV PET/CT. Compared to SAFOV, LAFOV imaging detected 52 additional findings in 27 patients (p < 0.05). The per-lesion agreement was 76% (p < 0.05). Of the additional lesions identified by LAFOV PET/CT, 42% were confirmed as true positive. LAFOV findings led to changes in clinical management in 15% of patients, including major therapeutic changes in 68% of these cases. CONCLUSION: LAFOV PET/CT significantly improved lesion detection and influenced clinical decision-making. Further prospective studies are required to validate these findings and fully assess LAFOV systems clinical utility. TRIAL REGISTRATION: Not applicable.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Di Franco M, Di Giorgio A, Cuzzani G, et al. Clinical added value of LAFOV PET/CT in patients undergoing same-day [18 F]FDG SAFOV PET/CT scans: an initial experience report and explorative study. Eur J Nucl Med Mol Imaging. 2025. PMID: 41134324. doi:10.1007/s00259-025-07611-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。